Korean J Obstet Gynecol.  1998 Jan;41(1):99-104.

A Clinical Study of Borderline Malignant Tumors of the Ovary

Abstract

Borderline tumors which may comprise 10% of ovarian neoplasms, occur predominantly in premenopausal women, and associated with a very good prognosis. This tumor has some but not all of the histologic characteristics of malignancy: stratification of epithelial cells with nuclear atypia and increased mitotic activity but without stromal invasion. The principal treatment of borderline ovarain tumors is surgical resection of the primary tumor. There is no evidence that either subsequent chemotherapy or radiation therapy improves survival. These studies were presented of the forty-three cases of borderline malignant ovarian tumors who had been treated at Korea University Hospital from 1989 to 1995. The follow up period was average 33 months (range, 1 to 77). The incidence of borderline malignant ovarian tumor was 18.9%. The mean age was 38.2 years (range, 18 to 76). The most common chief complaint was palpable mass (37.2%). According to surgical staging (FIGO), stage I and stage III were 40 cases, 3 cases respectively. Histologic subtypes were mucinous in 32 cases (74.4%), serous in 10 cases (23.3%) and mixed epithelial papillary m llerian type in 1 cases (2.3%). All patients underwent primary surgical treatment. Conservative surgery (unilateral oophorectomy or cystectomy) were performed in 25 patients (58.1%) at early stage. Twenty-six cases (60.5%) received adjuvant postoperative chemotherapy. Overall survival rate was 95.3%.

Keyword

Ovarian tumor; Borderline malignancy

MeSH Terms

Drug Therapy
Epithelial Cells
Female
Follow-Up Studies
Humans
Incidence
Korea
Mucins
Ovarian Neoplasms
Ovariectomy
Ovary*
Prognosis
Survival Rate
Mucins
Full Text Links
  • KJOG
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr